Increased Mortality with Intermediate Ascitic Polymorphonuclear Cell Counts Amongst Patients with Cirrhosis: Time to

Shahid Habib1, Michael Ball2, Chris Thomas2

  • 1Liver Institute PLLC, Tucson, AZ 85716, USA.

Abstract

Insights

Spontaneous bacterial peritonitis (SBP) diagnosis using polymorphonuclear cell counts may miss mortality risks. Intermediate cell counts and low ascitic albumin indicate higher long-term mortality in cirrhosis patients.

Area of Science:

  • Hepatology
  • Gastroenterology
  • Internal Medicine

Background:

  • Spontaneous bacterial peritonitis (SBP) is a severe complication in patients with decompensated cirrhosis and ascites.
  • Current diagnosis relies on ascitic fluid polymorphonuclear (A-PMN) cell count ≥ 250 cells/high-power field (HPF).

Purpose of the Study:

  • To evaluate the prognostic value of A-PMN counts and ascitic fluid albumin in predicting mortality in cirrhotic patients with ascites.
  • To determine if current diagnostic thresholds for SBP adequately identify patients at risk for mortality.

Main Methods:

  • Retrospective cohort study of 117 hospitalized patients with decompensated cirrhosis and ascites.
  • Patients were stratified by A-PMN counts (≤50, 51-249, ≥250 cells/HPF), ascitic white blood cell (WBC) count, and albumin levels.
  • Mortality risk was assessed at 28, 90, and 365 days post-paracentesis.

Main Results:

  • Patients with A-PMN ≤ 50 cells/HPF had the lowest 28-day mortality (8%).
  • Intermediate A-PMN counts (51-249 cells/HPF) were associated with significantly higher 90-day and 365-day mortality.
  • Low ascitic fluid albumin (≤1.0 g/dL) independently predicted increased 365-day mortality.

Conclusions:

  • Standard binary A-PMN thresholds may not fully capture mortality risk in SBP.
  • Intermediate A-PMN counts and low ascitic albumin are crucial indicators of increased long-term mortality.
  • More nuanced diagnostic and prognostic criteria are needed for SBP evaluation in cirrhotic patients.

Related Concept Videos

Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
614
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
476
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
271
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
349
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
498
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
876